Chemo-Free Regimen May Be Frontline Option for HR+, HER2+ Metastatic Breast Cancer
Anastrozole plus palbociclib, trastuzumab, and pertuzumab may provide a chemotherapy-free frontline treatment option for HR+, HER2+ metastatic breast cancer. Anastrozole plus palbociclib, trastuzumab, and pertuzumab may provide a chemotherapy-free frontline treatment option for HR+, HER2+ metastatic breast cancer.